Emerging New Standard of Care for HER2 Breast Cancer
Dr. Stephen Malamud, Mount Sinai
Save to PDF
January 3, 2018
Dr. Malamud describes some significant improvements in progression-free survivalĀ in patients with breast cancer who haveĀ received targeted therapies.